KFDA of Korea solicited a risk assessment of the branched sugar-based transfer enzyme of genetically modified food additives.

, September 21, K.K.,
. The FDA
released a draft of the
Risk Assessment
Report on The Transfer
Gene
Food Additives
Branching Glycosytransferase

to solicit opinions on the risk assessment report from the community as of October 20, 2015.branch glycosyl transfer enzyme as a processing aid in branch chain starch production, used in the production of new properties such as high solubility and low viscosity. The specific action of the enzyme is hydrolyzed alpha-1, 4-D-sugar binding, forming an alpha-1, 6-D-sugar binding at the end, thus generating starch branching structure.the main content of the risk assessment report was the insertion of the branching glycosylcransferase gene from R. obamensis source into Bacillus spores (Bacillus subtilis) to improve the productivity of branched glycosyl transferase.inserted into the Rhodothermus obamensis-sourced gene, isolates refined branch glycosyl transferase, which is used as an enzyme preparation. The enzyme preparation after a number of enrichment and filtration processes, the final product does not contain the production of strains.the risk assessment report made an assessment of the safety of its host, GM technology, GM deformants, etc. as GM food additives, and the appropriateness of the additives will be evaluated separately.Denmark (2009), the United States (2009), JECFA (2009) and France (2010) have certified their security.link to the original text:

the
.